Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;23(2):e13369.
doi: 10.1111/obr.13369. Epub 2021 Nov 14.

Impact of risk of generalizability biases in adult obesity interventions: A meta-epidemiological review and meta-analysis

Affiliations
Review

Impact of risk of generalizability biases in adult obesity interventions: A meta-epidemiological review and meta-analysis

Michael W Beets et al. Obes Rev. 2022 Feb.

Abstract

Biases introduced in early-stage studies can lead to inflated early discoveries. The risk of generalizability biases (RGBs) identifies key features of feasibility studies that, when present, lead to reduced impact in a larger trial. This meta-study examined the influence of RGBs in adult obesity interventions. Behavioral interventions with a published feasibility study and a larger scale trial of the same intervention (e.g., pairs) were identified. Each pair was coded for the presence of RGBs. Quantitative outcomes were extracted. Multilevel meta-regression models were used to examine the impact of RGBs on the difference in the effect size (ES, standardized mean difference) from pilot to larger scale trial. A total of 114 pairs, representing 230 studies, were identified. Overall, 75% of the pairs had at least one RGB present. The four most prevalent RGBs were duration (33%), delivery agent (30%), implementation support (23%), and target audience (22%) bias. The largest reductions in the ES were observed in pairs where an RGB was present in the pilot and removed in the larger scale trial (average reduction ES -0.41, range -1.06 to 0.01), compared with pairs without an RGB (average reduction ES -0.15, range -0.18 to -0.14). Eliminating RGBs during early-stage testing may result in improved evidence.

Keywords: intervention; pilot; scaling; translation.

PubMed Disclaimer

Conflict of interest statement

No conflict of interest statement.

Figures

FIGURE 1
FIGURE 1
Diagram of search procedures of locating pilot studies and larger scale trial pairs
FIGURE 2
FIGURE 2
PRISMA diagram of systematic literature search and final studies included in analyses
FIGURE 3
FIGURE 3
Classification of the presence (red circle) and absence (green circle) risk of generalizability biases across pilot and larger scale trial pairs
FIGURE 4
FIGURE 4
Forest plot of the change in the standardized difference in means (SDM) of the presence, absence, or carry forward of risk of generalizability biases from a pilot/feasibility study to a larger scale trial. No pairs contained directional conclusion bias in both the pilot and larger scale trial. Intervention duration, intervention intensity, and measurement describe differences between smaller and larger scale studies, so they cannot be present in both studies
FIGURE 5
FIGURE 5
Z value distribution of outcomes in larger scale trials by the absence (green line) of risk of generalizability bias (RGB), RGB present in pilot and absent in larger scale trial (red distribution), and RGB present in both pilot and larger scale trial (blue distribution). Positive z values indicate that the intervention was better than the control group, and negative z values indicate that the control group was better than the intervention group. Solid vertical lines represent z ± 1.96 (p = 0.05); dashed vertical lines represent z ± 2.58 (p = 0.005)

References

    1. Czajkowski SM, Powell LH, Adler N, et al. From ideas to efficacy: the ORBIT model for developing behavioral treatments for chronic diseases. Health Psychol. 2015;34(10):971‐982. - PMC - PubMed
    1. Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M. Reenvisioning clinical science: unifying the discipline to Improve the public health. Clin Psychol Sci. 2014;2(1):22‐34. - PMC - PubMed
    1. National Institutes of Health , National Institute of Diabetes and Digestive and Kidney Diseases . Small R01s for clinical trials targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required). National Institutes of Health. https://grants.nih.gov/grants/guide/pa-files/pas-20-160.html. Published 2020. Accessed April 1st, 2021.
    1. Pearson N, Naylor PJ, Ashe MC, Fernandez M, Yoong SL, Wolfenden L. Guidance for conducting feasibility and pilot studies for implementation trials. Pilot Feasibility Stud. 2020;6(1):167. - PMC - PubMed
    1. McCrabb S, Mooney K, Elton B, Grady A, Yoong SL, Wolfenden L. How to optimise public health interventions: a scoping review of guidance from optimisation process frameworks. BMC Public Health. 2020;20(1):1849. - PMC - PubMed